Patents by Inventor Stella M. Robertson

Stella M. Robertson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF STEROIDS TO TREAT PERSONS SUFFERING FROM OCULAR DISORDERS
    Publication number: 20090181933
    Abstract: Methods and compositions for treating retinal edema and NPDR are disclosed.
    Type: Application
    Filed: January 11, 2008
    Publication date: July 16, 2009
    Inventors: David P. Bingaman, Abbot F. Clark, Rajni Jani, Stella M. Robertson
  • Use of steroids to treat persons suffering from ocular disorders
    Publication number: 20040171598
    Abstract: Methods and compositions for treating retinal edema and NPDR are disclosed.
    Type: Application
    Filed: February 4, 2004
    Publication date: September 2, 2004
    Inventors: David P. Bingaman, Abbot F. Clark, Rajni Jani, Stella M. Robertson
  • Formulations of glucocorticoids to treat pathologic ocular angiogenesis
    Publication number: 20040167109
    Abstract: Formulations of glucocorticoids alone and in combination with anecortave acetate are useful for preventing and treating pathologic ocular angiogenesis and associated edema.
    Type: Application
    Filed: February 5, 2004
    Publication date: August 26, 2004
    Inventors: David P. Bingaman, Abbot F. Clark, Rajni Jani, Stella M. Robertson
  • Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
    Publication number: 20040127472
    Abstract: Purpose: To evaluate clinical safety and efficacy of the angiostatic agent anecortave acetate for treatment of subfoveal choroidal neovascularization secondary to AMD.
    Type: Application
    Filed: June 26, 2003
    Publication date: July 1, 2004
    Inventors: Janice A. Jerdan, Patricia Zilliox, Stella M. Robertson
  • Prostanoid therapies for the treatment of glaucoma
    Publication number: 20020193441
    Abstract: Compositions and methods for the treatment of glaucoma and/or ocular hypertension in humans utilizing improved doses of certain prostaglandin derivatives and analogs are disclosed.
    Type: Application
    Filed: February 21, 2002
    Publication date: December 19, 2002
    Inventor: Stella M. Robertson
  • 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular disease
    Patent number: 5677335
    Abstract: The use of 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for treating ocular diseases with immune etiology is disclosed.
    Type: Grant
    Filed: July 2, 1996
    Date of Patent: October 14, 1997
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Laura Smith Lang
  • Ophthalmic compositions comprising emedastine and methods for their use
    Patent number: 5668133
    Abstract: Topical ophthalmic compositions comprising 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole and its ophthalmically acceptable acid addition salts have been found to be useful in treating ocular allergies, especially allergic conjunctivitis, giant papillary conjunctivitis, and vernal conjunctivitis.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: September 16, 1997
    Assignee: Alcon Laboratories, Inc.
    Inventors: John M. Yanni, Stella M. Robertson, Shigetoshi Okumura, Hitoshi Tanaka, Tadayuki Saito
  • Pharmaceutical compositions and methods of treatment of the corneal following laser irradiation
    Patent number: 5665373
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: September 9, 1997
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman Melvin Kunkle, Jr.
  • Topical ophthalmic formulations for treating allergic eye diseases
    Patent number: 5641805
    Abstract: Topical ophthalmic formulations of the invention contain as an active ingredient 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid or a pharmaceutically acceptable salt thereof. The formulations are useful for treating allergic eye diseases such as allergic conjunctivitis, vernal conjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 24, 1997
    Assignees: Alcon Laboratories, Inc., Kyowa Hakko Kogyo Co. Ltd.
    Inventors: Eiji Hayakawa, Masashi Nakakura, Stella M. Robertson, John Michael Yanni
  • Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
    Patent number: 5589185
    Abstract: Methods for treating the cornea following UV laser irradiation and resulting photoablation of corneal tissue are disclosed. The methods include administration of compositions of a non-steroidal antiinflammatory to the eye. Compositions for use in treating the cornea are also disclosed.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: December 31, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.
  • Pharmaceutical compositions and methods of treatment of the cornea following laser treatment
    Patent number: 5589184
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: December 31, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.
  • Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
    Patent number: 5582835
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: December 10, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.
  • 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
    Patent number: 5583150
    Abstract: The use of 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for treating ocular diseases with immune etiology is disclosed.
    Type: Grant
    Filed: October 4, 1994
    Date of Patent: December 10, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Laura S. Lang
  • Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
    Patent number: 5580570
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: December 3, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.
  • Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
    Patent number: 5573775
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: November 12, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.
  • Compositions and methods for treating the cornea inconjunction with laser irradiation
    Patent number: 5525349
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: November 1, 1994
    Date of Patent: June 11, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.
  • Ophthalmic compositions comprising emedastine and methods for their use
    Patent number: 5441958
    Abstract: Topical ophthalmic compositions comprising 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole and its ophthalmically acceptable acid addition salts have been found to be useful in treating allergic conjunctivitis and related ailments.
    Type: Grant
    Filed: December 8, 1993
    Date of Patent: August 15, 1995
    Assignee: Alcon Laboratories, Inc.
    Inventors: John M. Yanni, Stella M. Robertson, Shigetoshi Okumura, Hitoshi Tanaka, Tadayuki Saito
  • Pharmaceutical compositions and methods of treatment of the cornea in conjunction with laser irradiation
    Patent number: 5401509
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: July 25, 1994
    Date of Patent: March 28, 1995
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.
  • Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
    Patent number: 5401510
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: July 25, 1994
    Date of Patent: March 28, 1995
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.
  • Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
    Patent number: 5360611
    Abstract: Methods for treating the cornea following UV laser irradiation and resulting photoablation of corneal tissue are disclosed. The methods include administration of compositions of a non-steroidal antiinflammatory to the eye. Compositions for use in treating the cornea are also disclosed.
    Type: Grant
    Filed: August 4, 1993
    Date of Patent: November 1, 1994
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.